SCHEMBL6805058

SCHEMBL6805058

Cc1ccccc1CN(C)C(=O)c1cc(C=O)ccc1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HSP90AA1 P07900 1/20 0.46
KMT2A Q03164 2/20 0.45
APP P05067 3/20 0.43
MEN1 O00255 1/20 0.43
FFAR4 Q5NUL3 1/20 0.41
PTGER4 P35408 2/20 0.41
PTGER3 P43115 2/20 0.41
PTGER2 P43116 2/20 0.41
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
SLC1A5 Q15758 1/20 0.40
PTGER1 P34995 1/20 0.40
LTB4R Q15722 1/20 0.40
LTB4R2 Q9NPC1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6811278 0.89 KDM4E (0.46) KDM4EALDH1A1POLBL3MBTL1APP
SCHEMBL31056340 0.80 APP (0.58) KDM4EALDH1A1POLBL3MBTL1KMT2A
SCHEMBL2932061 0.80 ALDH1A1 (0.52) KDM4EALDH1A1POLBL3MBTL1KMT2A
SCHEMBL6807414 0.80 SGMS2 (0.52) KDM4EALDH1A1POLBL3MBTL1KMT2A
SCHEMBL2929421 0.80 KDM4E (0.54) KDM4EALDH1A1POLBL3MBTL1APP
SCHEMBL2933284 0.78 TSHR (0.46) KDM4EALDH1A1KMT2AMEN1TDP1
SCHEMBL2928131 0.77 KDM4E (0.47) KDM4EALDH1A1POLBL3MBTL1APP
SCHEMBL2932095 0.77 PDK1 (0.51) KDM4EALDH1A1POLBL3MBTL1APP
SCHEMBL1648045 0.77 ALDH1A1 (0.73) KDM4EALDH1A1POLBL3MBTL1LMNA
SCHEMBL6805062 0.77 ALDH1A1 (0.48) KDM4EALDH1A1POLBL3MBTL1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6740670-B2 SUCH AS 5-(((3-(N-METHYL-N-PHENYLAMINO)CARBONYL-4-(PHENYL-METHOXY)) -PHENYL)METHYLENE)-4-OXO-2-THIOXO-3-THIAZOLIDINE-ACETIC ACID OXFORD GLYCOSCIENCES (UK) LTD. (GB) 2004-05-25 US disclosed
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent OXFORD GLYCOSCIENCES (UK) LTD (GB) 2003-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216453-A1 Thiazolidine derivatives and its use as antifungal agent CYP3A7, TAS2R7, OXSR1 KDM4E 3752/4885ALDH1A1 2527/4885POLB 4579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.